Chimeric antigen receptor T cell immunotherapy in colorectal cancer: primetime yet?

ANZ J Surg. 2024 Jun;94(6):996-997. doi: 10.1111/ans.18926. Epub 2024 Mar 31.

Authors

Maria Kristina Vanguardia^{1

2}, Hannah Hassum¹, Sara Roth², Wendy Brown³, Joseph Cherng Huei Kong^{1

2}

Affiliations

¹ Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia.
² School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
³ Monash University and Department of General Surgery, Alfred Hospital, Melbourne, Victoria, Australia.

PMID: 38556773
DOI: 10.1111/ans.18926

No abstract available

MeSH terms

Colorectal Neoplasms* / immunology
Colorectal Neoplasms* / therapy
Humans
Immunotherapy, Adoptive* / methods
Receptors, Chimeric Antigen* / immunology
Receptors, Chimeric Antigen* / therapeutic use

Substances

Receptors, Chimeric Antigen